NEDD4L inhibited lung adenocarcinoma cell progression in vitro and in vivo via inducing the ubiquitination‐mediated Ubiquitin‐conjugating enzyme E2T (UBE2T) degradation, which repressed PI3K‐Akt signalling.38 Here, NEDD4L is linked to lung adenocarcinoma.